Measles is one of the most contagious infectious diseases and is a public health problem because of its high death rate, especially in young children. In most cases, measles is responsible in moderate forms, but it can be responsible for complications mainly respiratory and neurological. Macrophagic activation syndrome secondary to measles has been rarely reported in the literature. We report in this article the case of a 3 years old child who presented a macrophagic activation syndrome after measles, treated with boluses of methylprednisolone with good evolution.
Cite this paper
Taher, F. , Mrhar, S. , Fakiri, K. E. , Rada, N. , Draiss, G. and Bouskraoui, M. (2023). Measles Complicated with Macrophagic Activation Syndrome: A Case Report. Open Access Library Journal, 10, e9785. doi: http://dx.doi.org/10.4236/oalib.1109785.
Gonzalez, F., Vincent, F. and Cohen, Y. (2009) Infectious Macrophagic Activation Syndrome: Etiologies and Management. Resuscitation, 18, 284-290.
https://doi.org/10.1016/j.reaurg.2009.03.002
Cheikh, A., et al. (2015) Measles in Morocco: Epidemiological Profile and Impact of Vaccination Strategy. Advances in Therapy, 32,172-183.
https://doi.org/10.1007/s12325-015-0188-2
Muscat, M., Bang, H., Wohlfahrt, J., Glismann, S. and Molbak, K. (2009) Measles in Europe: An Epidemiological Assessment. Lancet, 373, 383-389.
https://doi.org/10.1016/S0140-6736(08)61849-8
WHO (2019) Immunization, Vaccines and Biologicals: New Measles Surveillance Data for 2019.
https://www.who.int/news/item/15-05-2019-new-measles-surveillance-data-for-2019
Lagousi, T., Korovessi, P., Panagouli, E., et al. (2020) A Rare Case of Measles-Associated Hemophagocytic Lymphohistiocytosis in an Infant. Cureus, 12, e8246.
https://doi.org/10.7759/cureus.8246
Thomas, W., et al. (2016) Haemophagocytic Lymphohistiocytosis: an elusive syndrome. Clinical Medicine, 16, 432-436.
https://doi.org/10.7861/clinmedicine.16-5-432
Indwar, P., et al. (2016) Reporting Measles Case Fatality due to Complications from a Tertiary Care Hospital of Kolkata, West Bengal 2011-2013. Journal of Family Medicine and Primary Care, 5, 777-779.
https://doi.org/10.4103/2249-4863.201161
Henter, J.I., et al. (2007) HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatric Blood and Cancer, 48, 124-131.
https://doi.org/10.1002/pbc.21039
Bichon, A., et al. (2017) Case Report: Ribavirin and Vitamin A in a Severe Case of Measles. Medicine, 96, e9154. https://doi.org/10.1097/MD.0000000000009154
Buda, P., Gietka, P., Ksiazyk, J.B. and Machaczka, M. (2018) The Influence of Various Therapeutic Regimens on Early Clinical and Laboratory Response and Outcome of Children with Secondary Hemophagocytic Lymphohistiocytosis. Archives of Medical Science, 14, 138-150. https://doi.org/10.5114/aoms.2015.56325
Pietrantonj, D., et al. (2020) Vaccines for Measles, Mumps, Rubella, and Varicella in Children. Cochrane Database of Systematic Reviews, 4, CD004407.
https://doi.org/10.1002/14651858.CD004407.pub4
